ISRG - Kewajiban jangka dawa marang modal Intuitive Corp

Simbol lan logo merek Intuitive Corp (ISRG)

Intuitive Surgical (ISRG) maintains a stable cash flow based on regular servicing and the sale of consumables for da Vinci systems. As a global pioneer in robotic surgery, the company implements high-precision technologies that streamline the work of physicians. The current figure is 0.00. This price chart reflects the asset's dynamics, which are currently pressured by logistical disruptions and international sanctions limiting equipment exports.

Intuitive Surgical Inc (ISRG): Utang jangka dawa marang modal saka 04.07.2022 nganti 27.10.2026
Barang utama Intuitive Surgical

When assessing the long-term risks of Intuitive Surgical (ISRG), an investor analyzes the ratio of liabilities with a maturity of over one year to equity, which determines the issuer's degree of financial autonomy. An analysis of the long-term debt-to-equity structure confirms the exceptional resilience of Intuitive Surgical (ISRG), whose "razor-and-blade" model ensures a stable cash flow from consumables, minimizing the need for debt financing.

Analisis pesaing

Rasio utang jangka dawa marang ekuitas Danaher Corporation|Becton, Dickinson and Company - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal STERIS Group (STE)|WST - Utang jangka dawa marang modal|Rasio utang jangka dawa marang modal baxter.com BAX|Utang jangka dawa marang modal MASI (Masimo)|STVN - Rasio tanggungan utang jangka dawa marang modal|TFX (Teleflex Inc) - Utang jangka dawa marang modal|Merit Medical Corp (MMSI) - Rasio utang jangka dawa marang ekuitas|NVST (Envista Holdings) - Utang jangka dawa marang modal|Utang jangka dawa marang modal ICUI|Utang jangka dawa marang ekuitas Dentsply Sirona (XRAY)|Utang jangka dawa marang ekuitas LeMaitre Vascular Inc LMAT|Rasio utang jangka dawa marang ekuitas AtriCure Corp|Koefisien utang jangka dawa marang modal STAAR Surgical Co STAA|Utang jangka dawa marang modal NAGE (ChromaDex Corp.)|ZIMV: Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas AngioDynamics|CERS (Cerus Corp.) - Rasio utang jangka dawa marang modal|TKNO: Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka dawa marang modal Monogram Orthopedics Inc. (MGRM)|Rasio utang jangka dawa marang ekuitas Sharps Technology, Inc.|Rasio silihan jangka dawa marang modal INFU (infusystem.com)|Utang jangka dawa marang ekuitas Utah Medical Products, Inc.|KRMD - Koefisien utang jangka dawa marang modal|Nyxoah, S.A. - Rasio utang jangka dawa marang ekuitas|MBOT: Utang jangka dawa marang modal|PDEX (Pro-Dex, Inc.) - Utang jangka dawa marang ekuitas|zentek.com (ZTEK) - Rasio utang jangka dawa marang ekuitas|Utang jangka dawa marang modal ELUT (Elutia)|Kewajiban jangka dawa marang modal MLSS|Utang jangka dawa marang ekuitas NEXGEL, Inc NXGL|Rasio utang jangka dawa marang modal retractable.com RVP|Rasio utang jangka dawa marang ekuitas Harvard Bioscience, Inc. (HBIO)|femasys.com - Rasio silihan jangka dawa marang modal|Utang jangka dawa marang ekuitas MHUA (Meihua Medical)|POAI - Rasio tanggungan utang jangka dawa marang modal|callanjmb.com - Utang jangka dawa marang modal|ATRI (Atrion Corporation Inc.) - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas NeuroMetrix, Inc. (NURO)